COMPASS Pathways plc (CMPS): Shareholders' Equity
-$52.85M
As of 2025-12-31
$84.53M
As of 2026-06-30
| Period ended | Shareholders' Equity | Change YoY | Source filing |
|---|---|---|---|
| 2025-12-31 | -$52.85M | n/m | 2026-03-24, Balance as of period end |
| 2024-12-31 | $154.69M | -31.5% | 2026-03-24, Balance as of period end |
| 2023-12-31 | $225.74M | +24.5% | 2025-02-27, Balance as of period end |
| 2022-12-31 | $181.28M | -36.3% | 2024-02-29, Balance as of period end |
| 2021-12-31 | $284.41M | +44.7% | 2024-02-29, Balance as of period end |
| 2020-12-31 | $196.56M | n/m | 2023-02-28, Balance as of period end |
| 2019-12-31 | -$30.39M | n/a | 2022-02-24, Balance as of period end |
Shareholders' Equity at similar companies
| Company | Year ended | Shareholders' Equity | Change YoY |
|---|---|---|---|
| COMPASS Pathways plc (CMPS) | 2025-12-31 | -$52.85M | n/m |
| Puma Biotechnology, Inc. (PBYI) | 2025-12-31 | $130.34M | +41.5% |
| Siga Technologies Inc (SIGA) | 2025-12-31 | $198.82M | -7.9% |
| Abeona Therapeutics Inc. (ABEO) | 2025-12-31 | $159.22M | +261.6% |
| UroGen Pharma Ltd. (URGN) | 2025-12-31 | -$105.47M | n/m |
| Foghorn Therapeutics Inc. (FHTX) | 2025-12-31 | -$108.50M | n/m |
| Evommune, Inc. (EVMN) | 2025-12-31 | $205.57M | n/m |
| Pliant Therapeutics, Inc. (PLRX) | 2025-12-31 | $181.21M | -40.4% |
| Evolus, Inc. (EOLS) | 2025-12-31 | -$23.11M | n/m |
Compare CMPS, PBYI, SIGA, ABEO side by side · Screen every company in Pharmaceutical Preparations ↗